Learn More
Medchemexpress LLC Monobenzone | 103-16-2 | MFCD10687031 | 99.9% | 200.24 | 100 G

Supplier: Medchemexpress LLC HY30272100G
Monobenzone is a potent skin depigmenting agent with potential for vitiligo research. It also acts as an inhibitor of RNR enzyme activity, targeting the RRM2 protein. This demonstrates significant anti-leukemia efficacy both in vitro and in vivo, by inhibiting acute myeloid leukemia (AML) cell proliferation and DNA synthesis, and inducing cell cycle arrest and apoptosis.
- Inhibits AML cell proliferation and DNA synthesis.
- Induces cell cycle arrest and apoptosis in various AML cell lines.
- Blocks DNA damage repair.
- Can overcome drug resistance in certain cell lines.
- Synergistically inhibits cell growth with Bcl-2 inhibitor.
- Induces skin depigmentation in mice.
- Effectively inhibits AML cell xenograft growth in nude mice with low toxicity.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.